Skip to content

Quality of Systematic Reviews Underlying Clinical Practice Guidelines

Quality of Systematic Reviews Underlying Clinical Practice Guidelines - Quality of Systematic Reviews underlying Clinical Practice Guidelines for STEMI

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000023124
Enrollment
100
Registered
2016-08-01
Start date
2016-07-04
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Methodological Quality and completeness of reporting as represented by the AMSTAR tool and PRISMA checklist

Interventions

None listed

Sponsors

Oklahoma State University Center for Health Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Clinical Practice Guidelines: 1. Clinical Practice Guidelines must be recognized by a national governmental or provider/professional organization. 2. Clinical Practice Guidelines must be in English. 3. Clinical Practice Guidelines must contain recommendations relevant to best practices in the diagnosis, treatment, and/or management of STEMI. Systematic Reviews: 1. Systematic Reviews must be in English. 2. Systematic Reviews must be peer-reviewed and published, or currently in press. 3. The Systematic Review must have performed a systematic search and synthesis of available evidence.

Exclusion criteria

Exclusion criteria: Clinical Practice Guidelines: 1. Clinical Practice Guidelines without reference lists and those without readily accessible reference lists such as those only accessible by email correspondence will be excluded. 2. Addendums published relevant to one or more recommendations for a CPG will be excluded. 2. CPGs not recognized by a professional organization or governmental body will be excluded. Systematic Reviews: 1. Systematic reviews of animal studies will be excluded.

Design outcomes

Primary

MeasureTime frame
Global Methodological Quality and Completeness of Reporting of Clinical Practice Guidelines as represented by underlying systematic reviews graded with the AMSTAR tool and PRISMA checklist, respectively

Secondary

MeasureTime frame
Proportion of recommendations in CPGs with underlying evidence based on Systematic Reviews vs proportion of recommendations not based on systematic reviews. Quality of evidence underlying key specific recommendations as represented by methodological quality and completeness of reporting of systematic reviews used for each key recommendation.

Countries

North America

Contacts

Public ContactMatt Vassar

Oklahoma State University Center for Health Sciences College of Osteopathic Medicine

matt.vassar@okstate.edu918-582-1972

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026